INR 3.25
(4.84%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 524 Thousand INR | 109.26% |
2022 | -2.59 Million INR | -610.44% |
2021 | -334 Thousand INR | -401.57% |
2020 | 104 Thousand INR | 49.41% |
2019 | 85 Thousand INR | -37.96% |
2018 | 2000.00 INR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 4.83 Million INR | 0.0% |
2023 Q1 | 171.5 Thousand INR | 105.93% |
2023 Q4 | -91 Thousand INR | -100.0% |
2023 Q2 | 343 Thousand INR | 100.0% |
2023 FY | - INR | 109.26% |
2023 Q3 | -45.5 Thousand INR | -113.27% |
2022 Q3 | -1.37 Million INR | -1951.35% |
2022 Q2 | 74 Thousand INR | 0.0% |
2022 FY | - INR | -610.44% |
2022 Q1 | 74 Thousand INR | 103.87% |
2022 Q4 | -2.89 Million INR | -110.95% |
2021 Q1 | 29.5 Thousand INR | 0.0% |
2021 FY | - INR | -401.57% |
2021 Q4 | -1.91 Million INR | -105.35% |
2021 Q3 | -931 Thousand INR | -160.9% |
2021 Q2 | 1.52 Million INR | 5082.41% |
2020 FY | - INR | 49.41% |
2019 FY | - INR | -37.96% |
2018 FY | - INR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 9.61 Billion INR | 99.995% |
Aurobindo Pharma Limited | 61.78 Billion INR | 99.999% |
Glenmark Life Sciences Limited | 6.86 Billion INR | 99.992% |
Granules India Limited | 8.6 Billion INR | 99.994% |
Indoco Remedies Limited | 2.64 Billion INR | 99.98% |
Ajanta Pharma Limited | 12.56 Billion INR | 99.996% |
Alkem Laboratories Limited | 24.19 Billion INR | 99.998% |
Alpa Laboratories Limited | 86.12 Million INR | 99.392% |
Brooks Laboratories Limited | 41.72 Million INR | 98.744% |
AstraZeneca Pharma India Limited | 2.35 Billion INR | 99.978% |
Bajaj HealthCare Limited | 444.51 Million INR | 99.882% |
Bliss GVS Pharma Limited | 1.47 Billion INR | 99.965% |
Dr. Reddy's Laboratories Limited | 88.27 Billion INR | 99.999% |
Eris Lifesciences Limited | 6.98 Billion INR | 99.992% |
FDC Limited | 4.4 Billion INR | 99.988% |
Glenmark Pharmaceuticals Limited | 11.34 Billion INR | 99.995% |
Gufic Biosciences Limited | 1.48 Billion INR | 99.965% |
Ind-Swift Laboratories Limited | 6.86 Billion INR | 99.992% |
Ipca Laboratories Limited | 13.29 Billion INR | 99.996% |
Jagsonpal Pharmaceuticals Limited | 323.46 Million INR | 99.838% |
Krebs Biochemicals & Industries Limited | -82.72 Million INR | 100.633% |
Lasa Supergenerics Limited | -65.08 Million INR | 100.805% |
Laurus Labs Limited | 8 Billion INR | 99.993% |
Lupin Limited | 36.96 Billion INR | 99.999% |
Mankind Pharma Limited | 28.09 Billion INR | 99.998% |
Medicamen Biotech Limited | 245.66 Million INR | 99.787% |
Medico Remedies Limited | 150.37 Million INR | 99.652% |
Megasoft Limited | 284.73 Million INR | 99.816% |
NATCO Pharma Limited | 18.79 Billion INR | 99.997% |
Piramal Pharma Limited | 13.05 Billion INR | 99.996% |
RPG Life Sciences Limited | 1.28 Billion INR | 99.959% |
Sigachi Industries Limited | 883.39 Million INR | 99.941% |
Sun Pharmaceutical Industries Limited | 138.36 Billion INR | 100.0% |
Suven Pharmaceuticals Limited | 4.67 Billion INR | 99.989% |
Syncom Formulations (India) Limited | 430.27 Million INR | 99.878% |
Unichem Laboratories Limited | 742.35 Million INR | 99.929% |
Wanbury Limited | 985.49 Million INR | 99.947% |
Windlas Biotech Limited | 781.72 Million INR | 99.933% |
ZIM Laboratories Limited | 462.09 Million INR | 99.887% |
Zydus Lifesciences Limited | 56.22 Billion INR | 99.999% |
Sun Pharma Advanced Research Company Limited | -3.73 Billion INR | 100.014% |
Divi's Laboratories Limited | 25.43 Billion INR | 99.998% |
Hester Biosciences Limited | 539.47 Million INR | 99.903% |
Procter & Gamble Health Limited | 3.01 Billion INR | 99.983% |
Amrutanjan Health Care Limited | 682.53 Million INR | 99.923% |
Bal Pharma Limited | 345.59 Million INR | 99.848% |
Strides Pharma Science Limited | 3.76 Billion INR | 99.986% |
Venus Remedies Limited | 711.8 Million INR | 99.926% |
Aarti Pharmalabs Limited | 3.9 Billion INR | 99.987% |
Nectar Lifesciences Limited | 1.56 Billion INR | 99.966% |
Shilpa Medicare Limited | 2.58 Billion INR | 99.98% |
Aarti Drugs Limited | 3.24 Billion INR | 99.984% |
IOL Chemicals and Pharmaceuticals Limited | 2.6 Billion INR | 99.98% |
Suven Life Sciences Limited | -992.78 Million INR | 100.053% |
Ind-Swift Limited | 1.06 Billion INR | 99.951% |
Valiant Laboratories Limited | 12.73 Million INR | 95.887% |
J. B. Chemicals & Pharmaceuticals Limited | 9.33 Billion INR | 99.994% |
Solara Active Pharma Sciences Limited | -2.82 Billion INR | 100.019% |
Themis Medicare Limited | 562.6 Million INR | 99.907% |
Hikal Limited | 2.69 Billion INR | 99.981% |
Torrent Pharmaceuticals Limited | 35 Billion INR | 99.999% |
Sequent Scientific Limited | 549.8 Million INR | 99.905% |
Novartis India Limited | 1.26 Billion INR | 99.959% |
Wockhardt Limited | 1.08 Billion INR | 99.951% |
Jubilant Pharmova Limited | 8 Billion INR | 99.993% |
Biofil Chemicals and Pharmaceuticals Limited | 13.06 Million INR | 95.988% |
Neuland Laboratories Limited | 4.74 Billion INR | 99.989% |
Morepen Laboratories Limited | 1.72 Billion INR | 99.97% |
Kilitch Drugs (India) Limited | 287.42 Million INR | 99.818% |
Mangalam Drugs & Organics Limited | 174.94 Million INR | 99.7% |